Ondřej Knotek
Lobbying Activity
Meeting with AbbVie
17 Nov 2025 · Critical Medicines Act
Meeting with ClonBio Group Ltd
13 Nov 2025 · Biotech Act and Omnibus
Meeting with Gerber Steel GmbH
22 Oct 2025 · Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL addressing the negative trade-related effects of global overcapacity on the Union steel market
Meeting with Hyundai Motor Europe
22 Oct 2025 · Review of the Regulation on CO2 Emissions of Cars and Vans
Meeting with SYNERGI
8 Oct 2025 · Climate Law 2040 target and Energy/Climate policies of the EU
Meeting with MEDICINES FOR EUROPE
16 Sept 2025 · To discuss Critical Medicines Act
Meeting with Johnson Johnson
5 Jun 2025 · Critical Medicines Act
Meeting with
21 May 2025 · E-Fuels
Meeting with MEDICINES FOR EUROPE
6 May 2025 · Urban Waste Water Directive
Meeting with Affordable Medicines Europe
24 Apr 2025 · Critical Medicines Act
Meeting with Alber & Geiger
23 Apr 2025 · CMA/MDR/PFAS
Meeting with
11 Mar 2025 · Circular Economy
Meeting with Hitachi Energy
19 Feb 2025 · Electricity grids
Meeting with BioMarin UK Limited
20 Mar 2024 · Pharmaceutical package
Meeting with GSK
8 Mar 2024 · Pharmaceutical package
Meeting with Bristol-Myers Squibb Company
20 Feb 2024 · Pharmaceutical package
Meeting with AbbVie
7 Feb 2024 · Pharmaceutical package
Meeting with Ipsen Pharma
1 Feb 2024 · Pharmaceutical package
Meeting with GSK
11 Jan 2024 · Pharmaceutical package
Meeting with PTC Therapeutics
9 Jan 2024 · Pharmaceutical package
Meeting with European Federation of Pharmaceutical Industries and Associations
13 Dec 2023 · Pharmaceutical package
Meeting with Novartis International AG
13 Dec 2023 · Pharmaceutical package and cardiovascular diseases
Meeting with European Confederation of Pharmaceutical Entrepreneurs
22 Nov 2023 · Pharmaceutical package